Latest News

Philadelphia Mayor Jim Kenney gives the keynote address at the announcement Tuesday. (Credit: Twitter.com/PhillyMayor)

The Ralston Center and its partners announced on Tuesday the launch of the “Age-Friendly West Philadelphia” initiative, a collaborative partnership two years in the making.

Services for West Philadelphia’s senior citizens are “plentiful,” but people don’t know where to look or whom to trust, said Ralston Center CEO Joseph Lukach. Ralston Center, a nearly 200-year-old organization dedicated to improving the health and quality of life of Philadelphia’s seniors, hopes to work with its 40-plus partners organizations — including the Penn Memory Center — to change that.

“Older West Philadelphians are more likely to live in poverty, to be obese or in poor health, and to face limitations with activities of daily living than older adults living elsewhere,” organizers wrote in the Ralston Center annual report.

“Leah’s Legends,” a team of five talented friends of the Penn Memory Center, is set to debut its inaugural improv show after months of lessons and practice.

Join us in laughing with and at Leah’s Legends 7 to 8 p.m. Sunday, June 12, at Christ Church Neighborhood House.

This event is free, but please RSVP to Felicia Greenfield by emailing felicia.greenfield@uphs.upenn.edu or calling 215-662-4523 by June 8.

Credit: Jade McKnight

A diagnosis of Alzheimer’s disease will not lead to a prescription for a “miracle cure,” but older adults with memory problems still need to see a specialist to avoid preventable issues.

Dr. Jason Karlawish, co-director of the Penn Memory Center, gave the keynote address Saturday at “Alzheimer’s: The New Normal,” a conversation on cognitive aging, Alzheimer’s disease, research, and caregiving.

“I don’t have a miracle cure,” he said. “I don’t even have a drug for Alzheimer’s that can dramatically slow the course of the disease. You’re right. But what I can tell you is that if you don’t understand where you’re at and what to expect in the future, you, the person with Alzheimer’s disease, are a setup for a series of disasters,” including financial exploitation, hospitalization, and communication issues with patients’ families.

Watch a portion of his speech below:

Tigist Hailu, Penn Memory Center coordinator for diversity in research and education, has successfully graduated from the University of Pennsylvania’s Master of Public Health (MPH) Program.

“The Penn Memory Center and the Penn Health Brain Research Center take great pride in Tigist Hailu receiving her master’s in public health from the University of Pennsylvania,” said Dr. Jason Karlawish, co-director of the Penn Memory Center. “She’s learned skills and talents that are accelerating and expanding the Centers’ efforts to raise awareness and improve the cognitive health and well-being of older adults and their families. She’s an inspiration.”

Hailu oversees the Penn Memory Center’s multicultural recruitment with a particular focus on the African-American community in NACC and other research studies with the Penn Prevention Research Center’s Healthy Brain Research Network Center.

“I have been so impressed with Tigist’s creativity and determination,” said Dr. Carolyn Cannuscio, Hailu’s advisor in the MPH program. “Her work is so clearly motivated by a deep compassion for and commitment to her patients. She is a model for all our students.”

Tigist graduated from Franklin & Marshall College with a bachelor’s in public health psychology and Africana studies.

Dr. John Q. Trojanowski (center) and others listen to Queen Silvia of Sweden (second from left). Photo courtesy of the Swedish Society of Medicine.

Earlier this month, Penn Alzheimer’s Disease Core Center Director Dr. John Q. Trojanowski presented a lecture on “Experimental Transmission of Tau Pathology: Implications for Diagnosis and Therapy” at the 2016 Söderberg Prize Seminar at the Swedish Society of Medicine in Stockholm, Sweden.

This Seminar recognized Dr. Kaj Blennow, the first Alzheimer’s disease researcher to receive this award. Queen Silvia of Sweden, an avid Alzheimer’s disease research advocate, was in attendance to present the award.

(Credit: hopkinsmedicine.org)

A new clinical trial will likely lead to a change in physician management of dementia patients, said Penn Memory Center Co-Director Dr. David Wolk.

The $100 million Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) study, funded by Medicare, is testing the clinical value of PET scans, which can currently cost patients $5,000, according to an article published on www.philly.com. Medicare decided in 2013 not to cover the scans in most clinical cases, even though they can identify misformed protein found in Alzheimer’s patients. The decision could be overruled if IDEAS shows that more scans could lead to fewer expensive hospitalizations.

The Penn Healthy Brain Research Center is pleased to co-host the fourth and final installment of an international symposium on aging, cognitive decline, and the impact on financial services.

“Aging and Cognition: Maintaining Economic Security in Later Life” will be held May 9 and 10 at the Inn at Penn in Philadelphia. It follows similar symposia held in Tokyo, London, and Toronto.

Dr. Jason Karlawish, Penn Memory Center Co-Director, testifies before the Elder Justice Coordinating Council Wednesday, April 27, 2016. (Screenshot of livestream.)

The United States has taken long strides towards treating and preventing the medical issues associated with Alzheimer’s disease, but now is the time to include the nation’s banks and financial services industries in a national plan.

Testifying before the Elder Justice Coordinating Council (EJCC) Wednesday morning, Penn Memory Center Co-Director Dr. Jason Karlawish introduced “a new model to assure the financial security of aging Americans” he calls whealthcare.

“Among the first signs of cognitive changes caused by diseases such as Alzheimer’s disease, and cognitive aging as well, are changes in our capacity to manage our finances,” putting the banking and financial services industries on the front lines of screening for cognitive impairment, Karlawish said.

The Elder Justice Coordinating Council (EJCC) is bringing together leaders in government and research Wednesday morning, and a live stream of the meeting will be available here from 9 a.m. to noon: http://acl.gov/ejcc

The video was originally available here on www.pennadc.org, but it has since moved.

Dr. Jason Karlawish, co-director of the Penn Memory Center, presents “The House of Alzheimer’s Disease” at the Max Planck Institute for Human Development in Berlin this week.

Over the weekend, Dr. Jason Karlawish, co-director of the Penn Memory Center, joined colleagues from the University of Cambridge at Fondation Brocher in Hermance, Switzerland, for “The redefinition of Alzheimer’s disease and its social and ethical consequences. His co-organizers included Research Associate Milne Richard and Senior Research Associate Badger Shirlene.

The event brought together social scientists and ethicists to “explore the boundary between the clinical and research uses of biomarkers and how, as this boundary shifts, it changes how we study, care for and, as a society, approach Alzheimer’s disease,” according to the event’s website.